NOT-DA-21-040: Notice of Change to Key Dates for PA-21-110, "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)"

Notice of Change to Key Dates for PA-21-110, "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)"

Notice Number:

NOT-DA-21-040

Key Dates

Release Date:

February 11, 2021

Related Announcements

PA-21-110 - Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This notice informs applicants of changes to the Advisory Council Review dates for Funding Opportunity Announcement (FOA) PA-21-110, "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)".

The following section of PA-21-110 has been modified, as indicated below.

Currently reads:

Part 1. Overview Information

Key dates

Advisory Council Review

August 2021, January 2022, May 2022, August 2022, January 2023, May 2023, August 2023, January 2024, May 2024

Modified to Read (changes shown in bold italics):

Part 1. Overview Information

Key dates

Advisory Council Review

October 2021, January 2022, May 2022, October 2022, January 2023, May 2023, October 2023, January 2024, May 2024

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Amy B. Goldstein, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-4124
Email: amy.goldstein@nih.gov